APA

Kobbe G., Fenk R., Neumann F., Bernhardt A., Steidl U., Kondakci M., Graef T., Aivado M., Vaupel M., Huenerlituerkoglu A., Kronenwett R., Pape H., Hildebrand B., Germing U. & Haas R. (20050916). Transplantation of allogeneic CD34+-selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemia. : Cytotherapy.

Chicago

Kobbe G, Fenk R, Neumann F, Bernhardt A, Steidl U, Kondakci M, Graef T, Aivado M, Vaupel M, Huenerlituerkoglu A-N, Kronenwett R, Pape H, Hildebrand B, Germing U and Haas R. 20050916. Transplantation of allogeneic CD34+-selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemia. : Cytotherapy.

Harvard

Kobbe G., Fenk R., Neumann F., Bernhardt A., Steidl U., Kondakci M., Graef T., Aivado M., Vaupel M., Huenerlituerkoglu A., Kronenwett R., Pape H., Hildebrand B., Germing U. and Haas R. (20050916). Transplantation of allogeneic CD34+-selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemia. : Cytotherapy.

MLA

Kobbe G, Fenk R, Neumann F, Bernhardt A, Steidl U, Kondakci M, Graef T, Aivado M, Vaupel M, Huenerlituerkoglu A-N, Kronenwett R, Pape H, Hildebrand B, Germing U and Haas R. Transplantation of allogeneic CD34+-selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemia. : Cytotherapy. 20050916.